{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T11:37:09Z","timestamp":1788349029899,"version":"build-2803163510"},"reference-count":55,"publisher":"Bentham Science Publishers Ltd.","issue":"1","content-domain":{"domain":["eurekaselect.com"],"crossmark-restriction":true},"short-container-title":["CDT"],"published-print":{"date-parts":[[2020,12,31]]},"abstract":"<jats:sec>\n<jats:title\/>\n<jats:p>Our aim is to provide a narrative review regarding the prevalence, the associated pathophysiologic pathways and\nthe potential management methods of sexual dysfunction related to ablative surgical techniques for Benign Prostatic Enlargement (BPE). Men suffering from BPE are at high risk of sexual dysfunction due to the disease itself, comorbidities, and\npharmacological\/surgical treatments. Transurethral resection of the prostate, as the gold standard treatment option for BPE\nhas historically been associated with relatively high rates of postoperative sexual dysfunction problems, mainly retrograde\nejaculation but also erectile dysfunction. Ablative surgical techniques, including photoselective vaporization of the prostate\n(PVP), transurethral needle ablation (TUNA), Transurethral Microwave Therapy (TUMT), Convective Water Vapor Energy\nAblation (Rezum\u00ae) and Aquablation\u00ae have been proposed as treatment methods able to reduce treatment-related complications for BPE patients, including adverse effects on erectile and ejaculatory function, without compromising the efficacy\nrates for BPE. The neurovascular bundles can be damaged during TURP due to posterolateral capsular perforation. Ablative\ntechniques and especially PVP theoretically seems to skip this hazard as the distance created from the necrotic area to the\ncapsule is generally larger compared to the distance induced after TURP . However, indirect thermal injury of erectile\nnerves, which could be induced also by the majority of available ablative techniques could potentially lead to ED. Two special technical characteristics (physiological saline use for tissue ablation and real time penetration depth control) of\nAquablation\u00ae could be proved beneficial with regard to the effect of the method on erectile function. In general ablative\ntechniques seems to have minor impact on sexual function. However, low methodological quality characterize the most of\nthe studies included in this review mainly due to the impossibility, in many cases, to perform a blind randomization. Also in\nmany studies did not have erectile and ejaculatory function as primary outcomes limiting that way their statistical power to\nidentify significant variations. Management of sexual dysfunction problems arising from ablative surgeries for BPE treatment could be divided in two levels. Firstly, intraoperatively the avoidance of manipulation of crucial structures regarding\nejaculatory (bladder neck or ejaculatory ducts) and erectile function (neurovascular bundles) could possibly decrease the\nnegative effect of these procedures on sexual function. Thus, in this direction, modifications of classic ablative techniques\nhave been proposed resulting in encouraging outcomes regarding postoperative sexual function. Secondly, if EjD and\/or ED\nare established the already known treatment choices should be chosen in order sexual function rehabilitation to be achieved.\nThus, regarding ED: PDE5i daily or on demand remain the gold standard first line treatment choice followed by intracaver-nosal alprostadil injections in cases of failure, while penile prosthesis implantation must be kept as final definitive solution\nwhen all the other methods have failed. Regarding ejaculation disorders (retrograde ejaculation or anejaculation): medical\ntherapy with a-agonists (pseudoephedrine), sperm retrieval from the urine, bladder neck reconstruction, prostatic massage,\nelectroejaculation, penile vibratory stimulation and surgical sperm retrieval are the available treatment options. Further, high\nquality studies are required to investigate potential side effects of BPE surgery on sexual function and efficient treatment\nmethods to manage them.\n<\/jats:p>\n<\/jats:sec>","DOI":"10.2174\/1389450121666200925143916","type":"journal-article","created":{"date-parts":[[2020,9,28]],"date-time":"2020-09-28T05:50:28Z","timestamp":1601272228000},"page":"4-13","update-policy":"https:\/\/doi.org\/10.2174\/bsp_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["How can we Preserve Sexual Function after Ablative Surgery for Benign Prostatic Hyperplasia?"],"prefix":"10.2174","volume":"22","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3869-2888","authenticated-orcid":true,"given":"Ioannis","family":"Mykoniatis","sequence":"first","affiliation":[{"name":"Department of Urology, Jessa Hospital, Hasselt, Belgium; 2Faculty of medicine, Hasselt University, Hasselt, Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koenraad Van","family":"Renterghem","sequence":"additional","affiliation":[{"name":"Department of Urology, Jessa Hospital, Hasselt, Belgium; 2Faculty of medicine, Hasselt University, Hasselt, Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ioannis","family":"Sokolakis","sequence":"additional","affiliation":[{"name":"Department of Urology, Martha-Maria Hospital Nuremberg, Nuremberg, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"965","reference":[{"key":"ref=1","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1016\/j.euf.2017.11.004","volume":"3","author":"De Nunzio C.","year":"2017","unstructured":"De Nunzio C.; Roehrborn C.G.; Andersson K-E.; McVary K.T.; Erectile dysfunction and lower urinary tract symptoms. Eur Urol Focus 2017,3(4-5),352-363","journal-title":"Eur Urol Focus"},{"key":"ref=2","doi-asserted-by":"publisher","first-page":"O78","DOI":"10.1111\/luts.12220","volume":"11","author":"Liao L.","year":"2019","unstructured":"Liao L.; Chuang Y-C.; Liu S-P.; Effect of lower urinary tract symptoms on the quality of life and sexual function of males in China, Taiwan, and South Korea: Subgroup analysis of a cross-sectional, population-based study. Low Urin Tract Symptoms 2019,11(2),O78-O84","journal-title":"Low Urin Tract Symptoms"},{"key":"ref=3","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1007\/s11934-019-0930-4","volume":"20","author":"Zhao H.","year":"2019","unstructured":"Zhao H.; Kim H.H.; The complex relationship between lower urinary tract symptoms and sexual health. Curr Urol Rep 2019,20(10),58","journal-title":"Curr Urol Rep"},{"key":"ref=4","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/j.esxm.2019.09.003","volume":"8","author":"Gomes C.M.","year":"2020","unstructured":"Gomes C.M.; Averbeck M.A.; Koyama M.; Soler R.; Association among lower urinary tract symptoms, erectile function, and sexual satisfaction: Results from the Brazil LUTS study. Sex Med 2020,8(1),45-56","journal-title":"Sex Med"},{"key":"ref=5","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1038\/sj.ijir.3900622","volume":"12","author":"Braun M.","year":"2000","unstructured":"Braun M.; Wassmer G.; Klotz T.; Reifenrath B.; Mathers M.; Engelmann U.; Epidemiology of erectile dysfunction: results of the \u2018Cologne Male Survey\u2019. Int J Impot Res 2000,12(6),305-311","journal-title":"Int J Impot Res"},{"key":"ref=6","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1007\/s11934-018-0813-0","volume":"19","author":"Borchert A.","year":"2018","unstructured":"Borchert A.; Leavitt D.A.; A review of male sexual health and dysfunction following surgical treatment for benign prostatic hyperplasia and lower urinary tract symptoms. Curr Urol Rep 2018,19(8),66","journal-title":"Curr Urol Rep"},{"key":"ref=7","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1111\/bju.14057","volume":"121","author":"Roehrborn C.G.","year":"2018","unstructured":"Roehrborn C.G.; Manyak M.J.; Palacios-Moreno J.M.; A prospective randomised placebo-controlled study of the impact of dutasteride\/tamsulosin combination therapy on sexual function domains in sexually active men with lower urinary tract symptoms (LUTS) secondary to benign prostatic hyperplasia (BPH). BJU Int 2018,121(4),647-658","journal-title":"BJU Int"},{"key":"ref=8","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1097\/MOU.0000000000000247","volume":"26","author":"Chung A.","year":"2016","unstructured":"Chung A.; Woo H.H.; Preservation of sexual function when relieving benign prostatic obstruction surgically: can a trade-off be considered? Curr Opin Urol 2016,26(1),42-48","journal-title":"Curr Opin Urol"},{"key":"ref=9","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1016\/j.eururo.2010.04.027","volume":"58","author":"Bruy\u00e8re F.","year":"2010","unstructured":"Bruy\u00e8re F.; Puichaud A.; Pereira H.; Influence of photoselective vaporization of the prostate on sexual function: results of a prospective analysis of 149 patients with long-term follow-up. Eur Urol 2010,58(2),207-211","journal-title":"Eur Urol"},{"key":"ref=10","doi-asserted-by":"publisher","first-page":"592","DOI":"10.21037\/tau.2016.06.05","volume":"5","author":"Parnham A.","year":"2016","unstructured":"Parnham A.; Serefoglu E.C.; Retrograde ejaculation, painful ejaculation and hematospermia. Transl Androl Urol 2016,5(4),592-601","journal-title":"Transl Androl Urol"},{"key":"ref=11","doi-asserted-by":"publisher","first-page":"545","DOI":"10.3109\/00365599709030660","volume":"31","author":"Bieri S.","year":"1997","unstructured":"Bieri S.; Iselin C.E.; Rohner S.; Capsular perforation localization and adenoma size as prognostic indicators of erectile dysfunctional after transurethral prostatectomy. Scand J Urol Nephrol 1997,31(6),545-548","journal-title":"Scand J Urol Nephrol"},{"key":"ref=12","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1007\/s11934-011-0199-8","volume":"12","author":"Bruy\u00e8re F.","year":"2011","unstructured":"Bruy\u00e8re F.; The relationship between photoselective vaporization of the prostate and sexual function. Curr Urol Rep 2011,12(4),261-264","journal-title":"Curr Urol Rep"},{"key":"ref=13","doi-asserted-by":"publisher","first-page":"8","DOI":"10.4081\/aiua.2015.1.8","volume":"87","author":"Pavone C.","year":"2015","unstructured":"Pavone C.; Abbadessa D.; Scaduto G.; Sexual dysfunctions after transurethral resection of the prostate (TURP): evidence from a retrospective study on 264 patients. Arch Ital Urol Androl 2015,87(1),8-13","journal-title":"Arch Ital Urol Androl"},{"key":"ref=14","doi-asserted-by":"publisher","first-page":"1416","DOI":"10.1016\/S0022-5347(05)67209-6","volume":"164","author":"Lefaucheur J.P.","year":"2000","unstructured":"Lefaucheur J.P.; Yiou R.; Salomon L.; Chopin D.K.; Abbou C.C.; Assessment of penile small nerve fiber damage after transurethral resection of the prostate by measurement of penile thermal sensation. J Urol 2000,164(4),1416-1419","journal-title":"J Urol"},{"key":"ref=15","first-page":"20","volume":"26","author":"Roehrborn CG","year":"2019","unstructured":"Roehrborn CG; Teplitsky S; Das AK; Aquablation of the prostate: a review and update. Can J Urol 2019,26(AS1),20-4","journal-title":"Can J Urol"},{"key":"ref=16","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1080\/00365590902930824","volume":"43","author":"Soleimani M.","year":"2009","unstructured":"Soleimani M.; Hosseini S.Y.; Aliasgari M.; Dadkhah F.; Lashay A.; Amini E.; Erectile dysfunction after prostatectomy: an evaluation of the risk factors. Scand J Urol Nephrol 2009,43(4),277-281","journal-title":"Scand J Urol Nephrol"},{"key":"ref=17","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1016\/j.eururo.2015.07.054","volume":"69","author":"Thomas J.A.","year":"2016","unstructured":"Thomas J.A.; Tubaro A.; Barber N.; A Multicenter randomized noninferiority trial comparing greenLight-XPS laser vaporization of the prostate and transurethral resection of the prostate for the treatment of benign prostatic obstruction: Two-yr outcomes of the GOLIATH study. Eur Urol 2016,69(1),94-102","journal-title":"Eur Urol"},{"key":"ref=18","doi-asserted-by":"publisher","first-page":"1404","DOI":"10.1097\/01.ju.0000139541.68542.f6","volume":"172","author":"Te A.E.","year":"2004","unstructured":"Te A.E.; Malloy T.R.; Stein B.S.; Photoselective vaporization of the prostate for the treatment of benign prostatic hyperplasia: 12-month results from the first United States multicenter prospective trial. J Urol 2004,172(4 Pt 1),1404-1408","journal-title":"J Urol"},{"key":"ref=19","doi-asserted-by":"publisher","first-page":"965","DOI":"10.1016\/j.eururo.2005.07.001","volume":"48","author":"Bachmann A.","year":"2005","unstructured":"Bachmann A.; Sch\u00fcrch L.; Ruszat R.; Photoselective vaporization (PVP) versus transurethral resection of the prostate (TURP): a prospective bi-centre study of perioperative morbidity and early functional outcome. Eur Urol 2005,48(6),965-971","journal-title":"Eur Urol"},{"key":"ref=20","doi-asserted-by":"publisher","first-page":"1344","DOI":"10.1097\/01.ju.0000173913.41401.67","volume":"174","author":"Malek R.S.","year":"2005","unstructured":"Malek R.S.; Kuntzman R.S.; Barrett D.M.; Photoselective potassium-titanyl-phosphate laser vaporization of the benign obstructive prostate: observations on long-term outcomes. J Urol 2005,174(4 Pt 1),1344-1348","journal-title":"J Urol"},{"key":"ref=21","doi-asserted-by":"publisher","first-page":"1701","DOI":"10.1111\/j.1743-6109.2007.00574.x","volume":"4","author":"Paick J-S.","year":"2007","unstructured":"Paick J-S.; Um J.M.; Kim S.W.; Ku J.H.; Influence of high-power potassium-titanyl-phosphate photoselective vaporization of the prostate on erectile function: a short-term follow-up study. J Sex Med 2007,4(6),1701-1707","journal-title":"J Sex Med"},{"key":"ref=22","doi-asserted-by":"publisher","first-page":"822","DOI":"10.1016\/S0090-4295(97)00238-0","volume":"49","author":"Rosen R.C.","year":"1997","unstructured":"Rosen R.C.; Riley A.; Wagner G.; Osterloh I.H.; Kirkpatrick J.; Mishra A.; The international index of erectile function (IIEF): a multidimensional scale for assessment of erectile dysfunction. Urology 1997,49(6),822-830","journal-title":"Urology"},{"key":"ref=23","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1038\/sj.ijir.3900472","volume":"11","author":"Rosen R.C.","year":"1999","unstructured":"Rosen R.C.; Cappelleri J.C.; Smith M.D.; Lipsky J.; Pe\u00f1a B.M.; Development and evaluation of an abridged, 5-item version of the International Index of Erectile Function (IIEF-5) as a diagnostic tool for erectile dysfunction. Int J Impot Res 1999,11(6),319-326","journal-title":"Int J Impot Res"},{"key":"ref=24","doi-asserted-by":"publisher","first-page":"2669","DOI":"10.1111\/j.1743-6109.2008.00978.x","volume":"5","author":"Kavoussi P.K.","year":"2008","unstructured":"Kavoussi P.K.; Hermans M.R.; Maintenance of erectile function after photoselective vaporization of the prostate for obstructive benign prostatic hyperplasia. J Sex Med 2008,5(11),2669-2671","journal-title":"J Sex Med"},{"key":"ref=25","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1089\/pho.2014.3727","volume":"32","author":"Ouyang Y.","year":"2014","unstructured":"Ouyang Y.; Liu C.; Guan W.; Zhao Y.; Xu Y.; Wu Y.; Impact of 160 W Greenlight laser vaporization of the prostate on erectile function: a prospective randomized controlled trial with 1-year follow-up. Photomed Laser Surg 2014,32(8),463-467","journal-title":"Photomed Laser Surg"},{"key":"ref=26","doi-asserted-by":"publisher","first-page":"1245","DOI":"10.1089\/end.2013.0216","volume":"27","author":"Kumar A.","year":"2013","unstructured":"Kumar A.; Vasudeva P.; Kumar N.; Nanda B.; Jha S.K.; Mohanty N.; A prospective randomized comparative study of monopolar and bipolar transurethral resection of the prostate and photoselective vaporization of the prostate in patients who present with benign prostatic obstruction: a single center experience. J Endourol 2013,27(10),1245-1253","journal-title":"J Endourol"},{"key":"ref=27","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1007\/s11255-011-0029-4","volume":"44","author":"Hossack T.A.","year":"2012","unstructured":"Hossack T.A.; Woo H.H.; Sexual function outcome following photoselective vaporisation of the prostate. Int Urol Nephrol 2012,44(2),359-364","journal-title":"Int Urol Nephrol"},{"key":"ref=28","doi-asserted-by":"publisher","DOI":"10.1089\/end.2012.0376","author":"Kumar A.","year":"2012","unstructured":"Kumar A.; Vasudeva P.; Kumar N.; Nanda B.; Mohanty N.K.; Evaluation of the effect of photoselective vaporization of the prostate on sexual function in a prospective study: A single center experience of 150 patients. J Endourol 2012","journal-title":"J Endourol"},{"key":"ref=29","doi-asserted-by":"publisher","first-page":"1115","DOI":"10.1089\/end.2014.0170","volume":"28","author":"Kumar A.","year":"2014","unstructured":"Kumar A.; Vasudeva P.; Kumar N.; A prospective study on the effect of photoselective vaporization of prostate by 120-W high-performance system laser on sexual function. J Endourol 2014,28(9),1115-1120","journal-title":"J Endourol"},{"key":"ref=30","doi-asserted-by":"publisher","first-page":"e3862","DOI":"10.1097\/MD.0000000000003862","volume":"95","author":"Li Z.","year":"2016","unstructured":"Li Z.; Chen P.; Wang J.; Mao Q.; The impact of surgical treatments for lower urinary tract symptoms\/benign prostatic hyperplasia on male erectile function: A systematic review and network meta-analysis. Medicine (Baltimore) 2016,95(24),e3862","journal-title":"Medicine (Baltimore)"},{"key":"ref=31","doi-asserted-by":"publisher","first-page":"e02885","DOI":"10.1136\/bmjopen-2018-028855","volume":"9","author":"Lai S","year":"2019","unstructured":"Lai S; Peng P; Diao T; Hou H; Wang X; Zhang W; Comparison of photoselective green light laser vaporisation versus traditional transurethral resection for benign prostate hyperplasia: an updated systematic review and meta-analysis of randomised controlled trials and prospective studies. BMJ Open 2019,9(8),e02885","journal-title":"BMJ Open"},{"key":"ref=32","doi-asserted-by":"publisher","first-page":"1588","DOI":"10.1097\/00005392-199805000-00048","volume":"159","author":"Bruskewitz R.","year":"1998","unstructured":"Bruskewitz R.; Issa M.M.; Roehrborn C.G.; A prospective, randomized 1-year clinical trial comparing transurethral needle ablation to transurethral resection of the prostate for the treatment of symptomatic benign prostatic hyperplasia. J Urol 1998,159(5),1588-1593","journal-title":"J Urol"},{"key":"ref=33","doi-asserted-by":"publisher","first-page":"2336","DOI":"10.1097\/01.ju.0000127761.87421.a0","volume":"171","author":"Hill B.","year":"2004","unstructured":"Hill B.; Belville W.; Bruskewitz R.; Issa M.; Perez-Marrero R.; Roehrborn C.; Terris M.; Naslund M.; Transurethral needle ablation versus transurethral resection of the prostate for the treatment of symptomatic benign prostatic hyperplasia: 5-year results of a prospective, randomized, multicenter clinical trial. J Urol 2004,171(6 Pt 1),2336-2340","journal-title":"J Urol"},{"key":"ref=34","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1089\/08927790360587432","volume":"17","author":"Cimentepe E.","year":"2003","unstructured":"Cimentepe E.; Unsal A.; Saglam R.; Randomized clinical trial comparing transurethral needle ablation with transurethral resection of the prostate for the treatment of benign prostatic hyperplasia: results at 18 months. J Endourol 2003,17(2),103-107","journal-title":"J Endourol"},{"key":"ref=35","doi-asserted-by":"publisher","first-page":"500","DOI":"10.1038\/aja.2010.33","volume":"12","author":"Frieben R.W.","year":"2010","unstructured":"Frieben R.W.; Lin H-C.; Hinh P.P.; Berardinelli F.; Canfield S.E.; Wang R.; The impact of minimally invasive surgeries for the treatment of symptomatic benign prostatic hyperplasia on male sexual function: a systematic review. Asian J Androl 2010,12(4),500-508","journal-title":"Asian J Androl"},{"key":"ref=36","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1186\/1471-2490-6-14","volume":"6","author":"Bouza C.","year":"2006","unstructured":"Bouza C.; L\u00f3pez T.; Magro A.; Navalpotro L.; Amate J.M.; Systematic review and meta-analysis of Transurethral Needle Ablation in symptomatic Benign Prostatic Hyperplasia. BMC Urol 2006,6,14","journal-title":"BMC Urol"},{"key":"ref=37","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1016\/S0022-5347(01)61930-X","volume":"161","author":"Francisca E.A.","year":"1999","unstructured":"Francisca E.A.; d\u2019Ancona F.C.; Meuleman E.J.; Debruyne F.M.; de la Rosette J.J.; Sexual function following high energy microwave thermotherapy: results of a randomized controlled study comparing transurethral microwave thermotherapy to transurethral prostatic resection. J Urol 1999,161(2),486-490","journal-title":"J Urol"},{"key":"ref=38","doi-asserted-by":"publisher","first-page":"1804","DOI":"10.1016\/j.juro.2010.12.054","volume":"185","author":"Mynderse L.A.","year":"2011","unstructured":"Mynderse L.A.; Roehrborn C.G.; Partin A.W.; Preminger G.M.; Cot\u00e9 E.P.; Results of a 5-year multicenter trial of a new generation cooled high energy transurethral microwave thermal therapy catheter for benign prostatic hyperplasia. J Urol 2011,185(5),1804-1810","journal-title":"J Urol"},{"key":"ref=39","first-page":"CD004135","author":"Hoffman R.M.","year":"2012","unstructured":"Hoffman R.M.; Monga M.; Elliott S.P.; Microwave thermotherapy for benign prostatic hyperplasia. Cochrane Database Syst Rev 2012(9),CD004135","journal-title":"Cochrane Database Syst Rev"},{"key":"ref=40","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1177\/1756287218793084","volume":"10","author":"Westwood J.","year":"2018","unstructured":"Westwood J.; Geraghty R.; Jones P.; Rai B.P.; Somani B.K.; Rezum: a new transurethral water vapour therapy for benign prostatic hyperplasia. Ther Adv Urol 2018,10(11),327-333","journal-title":"Ther Adv Urol"},{"key":"ref=41","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1016\/j.urology.2018.12.041","volume":"126","author":"McVary K.T.","year":"2019","unstructured":"McVary K.T.; Rogers T.; Roehrborn C.G.; Rez\u016bm water vapor thermal therapy for lower urinary tract symptoms associated with benign prostatic hyperplasia: 4-year results from randomized controlled study. Urology 2019,126,171-179","journal-title":"Urology"},{"key":"ref=42","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1016\/j.urology.2004.04.056","volume":"64","author":"Rosen R.C.","year":"2004","unstructured":"Rosen R.C.; Catania J.; Pollack L.; Althof S.; O\u2019Leary M.; Seftel A.D.; Male sexual health questionnaire (MSHQ): scale development and psychometric validation. Urology 2004,64(4),777-782","journal-title":"Urology"},{"key":"ref=43","doi-asserted-by":"publisher","first-page":"924","DOI":"10.1016\/j.jsxm.2016.03.372","volume":"13","author":"McVary K.T.","year":"2016","unstructured":"McVary K.T.; Gange S.N.; Gittelman M.C.; Erectile and ejaculatory function preserved with convective water vapor energy treatment of lower urinary tract symptoms secondary to benign prostatic hyperplasia: Randomized controlled study. J Sex Med 2016,13(6),924-933","journal-title":"J Sex Med"},{"key":"ref=44","doi-asserted-by":"publisher","first-page":"1728","DOI":"10.1016\/j.jsxm.2018.10.006","volume":"15","author":"McVary K.T.","year":"2018","unstructured":"McVary K.T.; Rogers T.; Mahon J.; Gupta N.K.; Is sexual function better preserved after water vapor thermal therapy or medical therapy for lower urinary tract symptoms due to benign prostatic hyperplasia? J Sex Med 2018,15(12),1728-1738","journal-title":"J Sex Med"},{"key":"ref=45","doi-asserted-by":"publisher","first-page":"159","DOI":"10.2147\/RRU.S143679","volume":"9","author":"Darson M.F.","year":"2017","unstructured":"Darson M.F.; Alexander E.E.; Schiffman Z.J.; Procedural techniques and multicenter postmarket experience using minimally invasive convective radiofrequency thermal therapy with Rez\u016bm system for treatment of lower urinary tract symptoms due to benign prostatic hyperplasia. Res Rep Urol 2017,9,159-168","journal-title":"Res Rep Urol"},{"key":"ref=46","doi-asserted-by":"publisher","first-page":"207","DOI":"10.2147\/RRU.S119596","volume":"8","author":"Dixon C.M.","year":"2016","unstructured":"Dixon C.M.; Cedano E.R.; Pacik D.; Two-year results after convective radiofrequency water vapor thermal therapy of symptomatic benign prostatic hyperplasia. Res Rep Urol 2016,8,207-216","journal-title":"Res Rep Urol"},{"key":"ref=47","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1038\/s41391-017-0022-9","volume":"21","author":"Mollengarden D.","year":"2018","unstructured":"Mollengarden D.; Goldberg K.; Wong D.; Roehrborn C.; Convective radiofrequency water vapor thermal therapy for benign prostatic hyperplasia: a single office experience. Prostate Cancer Prostatic Dis 2018,21(3),379-385","journal-title":"Prostate Cancer Prostatic Dis"},{"key":"ref=48","doi-asserted-by":"publisher","first-page":"1507","DOI":"10.1016\/j.juro.2016.12.045","volume":"197","author":"Roehrborn C.G.","year":"2017","unstructured":"Roehrborn C.G.; Gange S.N.; Gittelman M.C.; Convective thermal therapy: Durable 2-year results of randomized controlled and prospective crossover studies for treatment of lower urinary tract symptoms due to benign prostatic hyperplasia. J Urol 2017,197(6),1507-1516","journal-title":"J Urol"},{"key":"ref=49","first-page":"8590","volume":"23","author":"MacRae C.","year":"2016","unstructured":"MacRae C.; Gilling P.; How I do it: Aquablation of the prostate using the AQUABEAM system. Can J Urol 2016,23(6),8590-8593","journal-title":"Can J Urol"},{"key":"ref=50","doi-asserted-by":"publisher","first-page":"923","DOI":"10.1111\/bju.13358","volume":"117","author":"Gilling P.","year":"2016","unstructured":"Gilling P.; Reuther R.; Kahokehr A.; Fraundorfer M.; Aquablation - image-guided robot-assisted waterjet ablation of the prostate: initial clinical experience. BJU Int 2016,117(6),923-929","journal-title":"BJU Int"},{"key":"ref=51","doi-asserted-by":"publisher","first-page":"1252","DOI":"10.1016\/j.juro.2017.12.065","volume":"199","author":"Gilling P.","year":"2018","unstructured":"Gilling P.; Barber N.; Bidair M.; WATER: A Double-Blind, Randomized, Controlled Trial of Aquablation vs Transurethral Resection of the Prostate in Benign Prostatic Hyperplasia. J Urol 2018,199(5),1252-1261","journal-title":"J Urol"},{"key":"ref=52","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1016\/j.urology.2018.12.002","volume":"125","author":"Gilling P.J.","year":"2019","unstructured":"Gilling P.J.; Barber N.; Bidair M.; Randomized Controlled Trial of Aquablation versus Transurethral Resection of the Prostate in Benign Prostatic Hyperplasia: One-year Outcomes. Urology 2019,125,169-173","journal-title":"Urology"},{"key":"ref=53","first-page":"1702","volume":"34","author":"Xu Z.","year":"2014","unstructured":"Xu Z.; Liu J.; Zheng X.; Pu X.; Protective effect of preserving bladder neck integrity on erectile function in patients undergoing plasmakinetic vaporization for benign prostatic hyperplasia. Nan Fang Yi Ke Da Xue Xue Bao 2014,34(11),1702-1704","journal-title":"Nan Fang Yi Ke Da Xue Xue Bao"},{"key":"ref=54","unstructured":"V403: The impact of Ejaculation-Preserving Photo-selective Vaporization of the Prostate (EP-PVP) on lower | AUA University","journal-title":"V403: The impact of Ejaculation-Preserving Photo-selective Vaporization of the Prostate (EP-PVP) on lower | AUA University"},{"key":"ref=55","doi-asserted-by":"publisher","first-page":"1074","DOI":"10.1016\/j.fertnstert.2015.09.024","volume":"104","author":"Mehta A.","year":"2015","unstructured":"Mehta A.; Sigman M.; Management of the dry ejaculate: a systematic review of aspermia and retrograde ejaculation. Fertil Steril 2015,104(5),1074-1081","journal-title":"Fertil Steril"}],"container-title":["Current Drug Targets"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/eurekaselect.com\/article\/download\/186297","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/186297\/article","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/eurekaselect.com\/article\/download\/186297","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,8,10]],"date-time":"2021-08-10T16:45:47Z","timestamp":1628613947000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.eurekaselect.com\/186297\/article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,12,31]]},"references-count":55,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,12,31]]}},"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/1389450121666200925143916","relation":{},"ISSN":["1389-4501"],"issn-type":[{"value":"1389-4501","type":"print"}],"subject":[],"published":{"date-parts":[[2020,12,31]]},"assertion":[{"value":"Peer Reviewed","order":0,"name":"review_status","label":"Review Status","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Single blind","order":1,"name":"review_process","label":"Review Process","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Checked with iThenticate","order":0,"name":"screening_status","label":"Screening Status","group":{"name":"plagiarism_screening","label":"Plagiarism Screening"}},{"value":"2020-03-08","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-05-28","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-07-08","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-12-31","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}